NEWS BRIEFS
NEWS BRIEFS
Coverage approved for prostate treatment
The Health Care Financing Administration has decided to approve national Medicare coverage for cryosurgical procedures for prostate cancer performed with Food and Drug Administration-approved devices.
This includes use of the Cryocare System from Endocare Inc., an Irvine, CA-based developer of prostate cancer technologies. Cryocare is used for minimally invasive targeted cryoablation prostate cancer procedures, and is the only temperature-monitored cryosurgical system specifically cleared by the FDA for the treatment of prostate cancer, the company says.
HCFA may boost coverage for diabetes management
The Health Care Financing Administration has proposed a rule outlining expanded Medicare coverage for outpatient diabetes self-management training services.
The proposed rule provides "uniform coverage" of services including educational and training opportunities furnished by qualified entities to beneficiaries that would be paid under Medicare’s physician fee schedule. Under the proposed rule, qualifying facilities can include clinics and end-stage renal disease facilities as well as regular hospitals.
A physician or qualified nonphysician practitioner (including clinical nurse specialists, clinical social workers, nurse practitioners, nurse midwives, and psychologists) must certify that the training is part of a comprehensive plan.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.